No Data
No Data
No Data
No Data
No Data
Express News | Oric Pharmaceuticals Inc - Expect to Report Updated Phase 1B Data in First Half of 2025
Moomoo 24/7Apr 15 16:15 ET
Express News | Oric Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1B Trial of Oric-114 in Patients With Mutated Nsclc
Moomoo 24/7Apr 15 16:15 ET
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN)
TipRanksApr 9 07:40 ET
ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of
GlobeNewswireApr 5 16:30 ET
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of
GlobeNewswireApr 4 16:30 ET
Oric Pharmaceuticals Bolsters Incentive Plan to Attract Talent
TipRanksMar 29 16:33 ET
No Data
No Data